Literature DB >> 33654733

Transcervical Mouse Infections with Chlamydia trachomatis and Determination of Bacterial Burden.

Karthika Rajeeve1, Rajeeve Sivadasan2.   

Abstract

Chlamydia trachomatis is an obligate human pathogen. It infects the genital tract of humans ascending into the fallopian tube, exacerbated by chronic pelvic pain, pelvic inflammatory disease, and fallopian tube scaring resulting in infertility and other malignancies. The major hurdle in controlling chlamydial spread is that the infection remains asymptomatic, thus leading to chronic, recurrent and persistent infections, with no vaccines developed so far. Being a human pathogen, we do not have an in vivo model of C. trachomatis infection. C. trachomatis do not cause ascending infections and fallopian tube pathology in the mouse urogenital tract when infected vaginally. To overcome this hurdle trans cervical method of infection must be adapted. In this protocol the method of establishing trans-cervical Chlamydial infection with the procedure to determine the bacterial load is detailed. This method will facilitate to deliver the bacteria past the cervix establishing an ascending infection into the uterine horns reciprocating human fallopian tube infections.
Copyright © 2020 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  Bacterial burden; Chlamydia trachomatis; Hydrosalphinx; Transcervical infection

Year:  2020        PMID: 33654733      PMCID: PMC7842350          DOI: 10.21769/BioProtoc.3506

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  16 in total

1.  Detailed protocol for purification of Chlamydia pneumoniae elementary bodies.

Authors:  Sanghamitra Mukhopadhyay; Alejandra P Clark; Erin D Sullivan; Richard D Miller; James T Summersgill
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

Review 2.  The chlamydial developmental cycle.

Authors:  Yasser M Abdelrahman; Robert J Belland
Journal:  FEMS Microbiol Rev       Date:  2005-11       Impact factor: 16.408

3.  Histopathologic changes related to fibrotic oviduct occlusion after genital tract infection of mice with Chlamydia muridarum.

Authors:  Anita A Shah; Justin H Schripsema; Mohammad T Imtiaz; Ira M Sigar; John Kasimos; Peter G Matos; Sandra Inouye; Kyle H Ramsey
Journal:  Sex Transm Dis       Date:  2005-01       Impact factor: 2.830

4.  Chlamydia trachomatis paralyses neutrophils to evade the host innate immune response.

Authors:  Karthika Rajeeve; Sudip Das; Bhupesh K Prusty; Thomas Rudel
Journal:  Nat Microbiol       Date:  2018-06-25       Impact factor: 17.745

Review 5.  Animal models for studying female genital tract infection with Chlamydia trachomatis.

Authors:  Evelien De Clercq; Isabelle Kalmar; Daisy Vanrompay
Journal:  Infect Immun       Date:  2013-07-08       Impact factor: 3.441

6.  Mouse strain-dependent variation in the course and outcome of chlamydial genital tract infection is associated with differences in host response.

Authors:  T Darville; C W Andrews; K K Laffoon; W Shymasani; L R Kishen; R G Rank
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

7.  Transcervical Inoculation with Chlamydia trachomatis Induces Infertility in HLA-DR4 Transgenic and Wild-Type Mice.

Authors:  Sukumar Pal; Delia F Tifrea; Guangming Zhong; Luis M de la Maza
Journal:  Infect Immun       Date:  2017-12-19       Impact factor: 3.441

8.  Disease outcome subsequent to primary and secondary urogenital infection with murine or human biovars of Chlamydia trachomatis.

Authors:  K H Ramsey; J L DeWolfe; R D Salyer
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

9.  Innate immunity is sufficient for the clearance of Chlamydia trachomatis from the female mouse genital tract.

Authors:  Gail L Sturdevant; Harlan D Caldwell
Journal:  Pathog Dis       Date:  2014-04-10       Impact factor: 3.166

10.  Differences in infectivity and induction of infertility: a comparative study of Chlamydia trachomatis strains in the murine model.

Authors:  Jennifer R Carmichael; Delia Tifrea; Sukumar Pal; Luis M de la Maza
Journal:  Microbes Infect       Date:  2012-12-31       Impact factor: 2.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.